MedPath

Based on the real world acupuncture and moxibustion treatment of amphetamine-type drug protracted withdrawal syndrome evidence-based clinical program optimization and efficacy evaluatio

Not Applicable
Conditions
Prolonged amphetamine-type drug withdrawal syndrome
Registration Number
ITMCTR2100004573
Lead Sponsor
Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Conform to the diagnosis of ATS withdrawal symptoms;
2. Urine test for methamphetamine is negative;
3. Aged 18 to 60 years male and female, with clear consciousness, no aphasia or mental retardation, education level above elementary school, able to understand the content of the scale and cooperate with treatment;
4. Did not participate in other clinical trials within 3 months;
5. Sign the informed consent form.

Exclusion Criteria

1. Patients with trauma or infection in the area receiving acupuncture;
2. Those who cannot tolerate acupuncture and electro-acupuncture or are allergic to acupuncture needles;
3. Women during pregnancy and lactation;
4. Severe heart, liver and kidney damage or suicidal tendency;
5. According to the judgment of the investigator, not suitable for patients participating in this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ACSA;
Secondary Outcome Measures
NameTimeMethod
HAMA;PSQI;HAMD;MoCA;SF-36;VAS;
© Copyright 2025. All Rights Reserved by MedPath